Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility

at Kansai International Airport

TOKYO, Apr. 21, 2022 /Kyodo JBN/ --

Nippon Express Holdings, Inc.

Nippon Express Co., Ltd. (hereinafter "Nippon Express"), a group company of Nippon Express Holdings, Inc., has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification, effective April 5, for its temperature-controlled facility "NX-PHARMA Logistics Hub Kansai Airport" located inside the international cargo area of Kansai International Airport.

 

Logo: https://kyodonewsprwire.jp/img/202204190123-O3-n3Z45H8m

 

Nippon Express has been participating in the KIX Pharma Community established by Kansai Airports Co., Ltd. and striving to acquire CEIV Pharma certification with the support of that company. As an air cargo forwarder operating a CEIV Pharma-certified facility, Nippon Express will be providing safe and high-quality temperature-controlled transport services at Kansai International Airport.

 

Image: https://kyodonewsprwire.jp/img/202204190123-O1-7Fu4lGKL

 

Photo: https://kyodonewsprwire.jp/img/202204190123-O2-63qjJio0

 

Nippon Express obtained the same certification in March 2021 for its Narita Temperature Controlled Hub near Narita Airport and has successfully constructed a pharmaceutical distribution network connecting gateway airports in eastern and western Japan.

 

The "Nippon Express Group Business Plan 2023 - Dynamic Growth" regards the pharmaceutical industry as a priority industry, and the NX Group has accordingly been enhancing and globally extending services to meet customer needs for increasingly sophisticated and diverse pharmaceutical logistics. The Group remains committed to providing a safe and secure pharmaceutical logistics platform.

 

(*) CEIV Pharma (The Center of Excellence for Independent Validators in Pharmaceutical Logistics): a quality certification program established by the International Air Transport Association (IATA) to cover the air transport of pharmaceutical products that sets out high standards encompassing the differing Good Distribution Practice (GDP) guidelines of countries around the world for the storage and transport of pharmaceuticals

 

Nippon Express website: https://www.nipponexpress.com/

 

NX Group's official LinkedIn account:

https://www.linkedin.com/company/nippon-express-group/

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

プレスリリース添付画像

Logo

| Small | Normal |
| Original |

Logo2

| Small | Normal |
| Original |

Photo

| Small | Normal |
| Original |

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

このプレスリリースを配信した企業・団体

  • ※購読している企業の確認や削除はWebプッシュ通知設定画面で行なってください
  • SNSでも最新のプレスリリース情報をいち早く配信中